IBDEI139 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17678,0)
 ;;=N92.5^^61^791^61
 ;;^UTILITY(U,$J,358.3,17678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17678,1,3,0)
 ;;=3^Irregular Menstruation,Other Spec
 ;;^UTILITY(U,$J,358.3,17678,1,4,0)
 ;;=4^N92.5
 ;;^UTILITY(U,$J,358.3,17678,2)
 ;;=^5015912
 ;;^UTILITY(U,$J,358.3,17679,0)
 ;;=N92.3^^61^791^80
 ;;^UTILITY(U,$J,358.3,17679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17679,1,3,0)
 ;;=3^Ovulation Bleeding
 ;;^UTILITY(U,$J,358.3,17679,1,4,0)
 ;;=4^N92.3
 ;;^UTILITY(U,$J,358.3,17679,2)
 ;;=^270570
 ;;^UTILITY(U,$J,358.3,17680,0)
 ;;=N89.7^^61^791^54
 ;;^UTILITY(U,$J,358.3,17680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17680,1,3,0)
 ;;=3^Hematocolpos
 ;;^UTILITY(U,$J,358.3,17680,1,4,0)
 ;;=4^N89.7
 ;;^UTILITY(U,$J,358.3,17680,2)
 ;;=^5015889
 ;;^UTILITY(U,$J,358.3,17681,0)
 ;;=N93.8^^61^791^5
 ;;^UTILITY(U,$J,358.3,17681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17681,1,3,0)
 ;;=3^Abnormal Uterine/Vaginal Bleeding,Other Spec
 ;;^UTILITY(U,$J,358.3,17681,1,4,0)
 ;;=4^N93.8
 ;;^UTILITY(U,$J,358.3,17681,2)
 ;;=^5015915
 ;;^UTILITY(U,$J,358.3,17682,0)
 ;;=N93.9^^61^791^6
 ;;^UTILITY(U,$J,358.3,17682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17682,1,3,0)
 ;;=3^Abnormal Uterine/Vaginal Bleeding,Unspec
 ;;^UTILITY(U,$J,358.3,17682,1,4,0)
 ;;=4^N93.9
 ;;^UTILITY(U,$J,358.3,17682,2)
 ;;=^5015916
 ;;^UTILITY(U,$J,358.3,17683,0)
 ;;=N92.4^^61^791^38
 ;;^UTILITY(U,$J,358.3,17683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17683,1,3,0)
 ;;=3^Excessive Bleeding in Premenopausal Period
 ;;^UTILITY(U,$J,358.3,17683,1,4,0)
 ;;=4^N92.4
 ;;^UTILITY(U,$J,358.3,17683,2)
 ;;=^5015911
 ;;^UTILITY(U,$J,358.3,17684,0)
 ;;=N95.0^^61^791^89
 ;;^UTILITY(U,$J,358.3,17684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17684,1,3,0)
 ;;=3^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,17684,1,4,0)
 ;;=4^N95.0
 ;;^UTILITY(U,$J,358.3,17684,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,17685,0)
 ;;=N95.1^^61^791^69
 ;;^UTILITY(U,$J,358.3,17685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17685,1,3,0)
 ;;=3^Menopausal/Female Climacteric States
 ;;^UTILITY(U,$J,358.3,17685,1,4,0)
 ;;=4^N95.1
 ;;^UTILITY(U,$J,358.3,17685,2)
 ;;=^5015927
 ;;^UTILITY(U,$J,358.3,17686,0)
 ;;=N97.0^^61^791^45
 ;;^UTILITY(U,$J,358.3,17686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17686,1,3,0)
 ;;=3^Female Infertility Associated w/ Anovulation
 ;;^UTILITY(U,$J,358.3,17686,1,4,0)
 ;;=4^N97.0
 ;;^UTILITY(U,$J,358.3,17686,2)
 ;;=^5015931
 ;;^UTILITY(U,$J,358.3,17687,0)
 ;;=N97.9^^61^791^46
 ;;^UTILITY(U,$J,358.3,17687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17687,1,3,0)
 ;;=3^Female Infertility,Unspec
 ;;^UTILITY(U,$J,358.3,17687,1,4,0)
 ;;=4^N97.9
 ;;^UTILITY(U,$J,358.3,17687,2)
 ;;=^5015935
 ;;^UTILITY(U,$J,358.3,17688,0)
 ;;=L29.2^^61^791^96
 ;;^UTILITY(U,$J,358.3,17688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17688,1,3,0)
 ;;=3^Pruritus Vulvae
 ;;^UTILITY(U,$J,358.3,17688,1,4,0)
 ;;=4^L29.2
 ;;^UTILITY(U,$J,358.3,17688,2)
 ;;=^100075
 ;;^UTILITY(U,$J,358.3,17689,0)
 ;;=R92.8^^61^791^7
 ;;^UTILITY(U,$J,358.3,17689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17689,1,3,0)
 ;;=3^Abnormal/Inconclusive Findings on Dx Imaging of Breast
 ;;^UTILITY(U,$J,358.3,17689,1,4,0)
 ;;=4^R92.8
 ;;^UTILITY(U,$J,358.3,17689,2)
 ;;=^5019712
 ;;^UTILITY(U,$J,358.3,17690,0)
 ;;=R87.619^^61^791^4
 ;;^UTILITY(U,$J,358.3,17690,1,0)
 ;;=^358.31IA^4^2
